Patient Representation and Advocacy for Alzheimer Disease in Germany and Israel

Silke Schicktanz, Nitzan Rimon-Zarfaty, Aviad Raz, Karin Jongsma

Research output: Contribution to journalArticlepeer-review

7 Scopus citations

Abstract

This paper analyses self-declared aims and representation of dementia patient organizations and advocacy groups (POs) in relation to two recent upheavals: the critique of social stigmatization and biomedical research focusing on prediction. Based on twenty-six semi-structured interviews conducted in 2016–2017 with members, service recipients, and board representatives of POs in Germany and Israel, a comparative analysis was conducted, based on a grounded theory approach, to detect emerging topics within and across the POs and across national contexts. We identified a heterogeneous landscape, with the only Israeli PO focusing strongly on caretakers, whereas in Germany several POs claim to represent this patient collective. Shared aims of all POs were fighting social stigma, balancing the loss of patients’ individual autonomy, and the well-being of caretakers. By highlighting the emergence of new groups of dementia self-advocacy against the more traditional advocacy by others, this study highlights how advocacy and representation in the context of AD are embedded in the discursive context of stigmatization and revised disease conception. Future developments in early diagnosis and prediction of dementia, with more affected people likely to conduct dementia self-advocacy, might challenge existing representation structures even more.

Original languageEnglish
Pages (from-to)369-380
Number of pages12
JournalJournal of Bioethical Inquiry
Volume15
Issue number3
DOIs
StatePublished - 1 Sep 2018

Keywords

  • Advocacy
  • Dementia
  • Disease conception
  • Patient organization
  • Representation
  • Stigma

Fingerprint

Dive into the research topics of 'Patient Representation and Advocacy for Alzheimer Disease in Germany and Israel'. Together they form a unique fingerprint.

Cite this